Tiziana Life Sciences (TLSA) Announces Study Results from In

Tiziana Life Sciences (TLSA) Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today

Tiziana Life Sciences (TLSA) Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Denver , Colorado , United States , Rocky Mountain , American , Tarun Singhal , John Corboy , Professor Of Neurology At Harvard Medical School , Access Program , Imaging Program In Neurologic Diseases At Brigham , Nasdaq , Tiziana Life Sciences Ltd , University Of Colorado Anschutz Medical Campus , American Academy Of Neurology , Meeting Of The American Academy Neurology , Mountain Multiple Sclerosis Center , Tiziana Life Sciences , American Academy , Foralumab Shows Promise , Neurologic Diseases , Mass General Brigham Healthcare System , Associate Professor , Harvard Medical School , Rocky Mountain Multiple Sclerosis Center , Colorado Anschutz Medical , Expanded Access Program , Annual Meeting , Nasal Foralumab Dampens Microglial Activation , Stabilizes Clinical Progression , Non Active Secondary Progressive ,